New Delhi, May 7 -- New Delhi: The Centre's move to consider stopping doorstep delivery of medicines has stirred up a hornet's nest, with an association of chemists and druggists strongly supporting the move, and e-pharmacy and e-commerce platforms opposing it. Meanwhile, doctors have jumped into the debate, advocating for continuing doorstep delivery, but with adequate checks and balances.

At a meeting on 24 April, the drugs technical advisory board (DTAB), India's top expert panel on drugs, had recommended that a sub-committee be set up to examine the possible withdrawal of a March 2020, pandemic-era notification that legally permitted such deliveries, according to the minutes of the meeting that Mint has reviewed, and according to thr...